Early Pandemic Influenza (2009 H1N1) in Ho Chi Minh City, Vietnam: A Clinical Virological and Epidemiological Analysis

Rogier van Doorn and colleagues analyze the initial outbreak, attempts at containment, and establishment of community transmission of pandemic H1N1 influenza in Ho Chi Minh City, Vietnam.

[1]  S. Günther,et al.  Detection of influenza A(H1N1)v virus by real-time RT-PCR. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[2]  F. Hayden,et al.  Selection of influenza virus mutants in experimentally infected volunteers treated with oseltamivir. , 2001, The Journal of infectious diseases.

[3]  P. Ward,et al.  Use of the oral neuraminidase inhibitor oseltamivir in experimental human influenza: randomized controlled trials for prevention and treatment. , 1999, JAMA.

[4]  U C de Silva,et al.  A preliminary analysis of the epidemiology of influenza A(H1N1)v virus infection in Thailand from early outbreak data, June-July 2009. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[5]  H. Klenk,et al.  Overexpression of the α-2,6-Sialyltransferase in MDCK Cells Increases Influenza Virus Sensitivity to Neuraminidase Inhibitors , 2003, Journal of Virology.

[6]  W. Edmunds,et al.  Delaying the International Spread of Pandemic Influenza , 2006, PLoS medicine.

[7]  M. Potier,et al.  Fluorometric assay of neuraminidase with a sodium (4-methylumbelliferyl-alpha-D-N-acetylneuraminate) substrate. , 1979, Analytical biochemistry.

[8]  A. Bermingham,et al.  Neuraminidase inhibitor resistance after oseltamivir treatment of acute influenza A and B in children. , 2009, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[9]  Novel influenza A investigation team.  Description of the early stage of pandemic (H1N1) 2009 in Germany, 27 April-16 June 2009. , 2009 .

[10]  Y. Leo,et al.  Effects of early oseltamivir therapy on viral shedding in 2009 pandemic influenza A (H1N1) virus infection. , 2010, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[11]  Y. Guan,et al.  Emergence of multiple genotypes of H5N1 avian influenza viruses in Hong Kong SAR , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[12]  B. Cowling,et al.  Estimation of the Serial Interval of Influenza , 2009, Epidemiology.

[13]  Tran Tinh Hien,et al.  Modelling the progression of pandemic influenza A (H1N1) in Vietnam and the opportunities for reassortment with other influenza viruses , 2009, BMC medicine.

[14]  P. Ward,et al.  Oral oseltamivir treatment of influenza in children , 2001, The Pediatric infectious disease journal.

[15]  Jacco Wallinga,et al.  A simple explanation for the low impact of border control as a countermeasure to the spread of an infectious disease. , 2008, Mathematical biosciences.

[16]  M. Feldman,et al.  Epidemic dynamics and antigenic evolution in a single season of influenza A , 2006, Proceedings of the Royal Society B: Biological Sciences.

[17]  R. Brookmeyer,et al.  Estimating incubation period distributions with coarse data , 2009, Statistics in medicine.

[18]  Marc Lipsitch,et al.  Estimates of the Prevalence of Pandemic (H1N1) 2009, United States, April–July 2009 , 2009, Emerging infectious diseases.

[19]  Yoshihiro Kawaoka,et al.  oseltamivir: descriptive study , 2022 .

[20]  T. Uyeki,et al.  National influenza surveillance in Vietnam, 2006-2007. , 2009, Vaccine.

[21]  J Wallinga,et al.  Epidemiology and control of influenza A(H1N1)v in the Netherlands: the first 115 cases. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[22]  W. Manosuthi.  Diagnostic Importance of Relative Lymphopenia as a Marker of Swine Influenza (H1N1) in Adults , 2009 .

[23]  Cornelius Bartels,et al.  Description of the early stage of pandemic (H1N1) 2009 in Germany, 27 April-16 June 2009. , 2009, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[24]  Bin Cao,et al.  Clinical features of the initial cases of 2009 pandemic influenza A (H1N1) virus infection in China. , 2009, The New England journal of medicine.

[25]  D. Swerdlow,et al.  Viral shedding duration of pandemic influenza A H1N1 virus during an elementary school outbreak--Pennsylvania, May-June 2009. , 2011, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[26]  Carl T. Bergstrom,et al.  Pandemic Influenza: Risk of Multiple Introductions and the Need to Prepare for Them , 2006, PLoS medicine.

[27]  E. Lyons,et al.  Pandemic Potential of a Strain of Influenza A (H1N1): Early Findings , 2009, Science.

[28]  D. Cummings,et al.  Strategies for containing an emerging influenza pandemic in Southeast Asia , 2005, Nature.

[29]  F. Hayden,et al.  Evaluation of Neuraminidase Enzyme Assays Using Different Substrates To Measure Susceptibility of Influenza Virus Clinical Isolates to Neuraminidase Inhibitors: Report of the Neuraminidase Inhibitor Susceptibility Network , 2003, Journal of Clinical Microbiology.

[30]  M. Lipsitch,et al.  How generation intervals shape the relationship between growth rates and reproductive numbers , 2007, Proceedings of the Royal Society B: Biological Sciences.

[31]  L. Meyers,et al.  The Shifting Demographic Landscape of Influenza , 2009, PLoS currents.

[32]  T. Uyeki,et al.  The burden of influenza in East and South‐East Asia: a review of the English language literature , 2008, Influenza and other respiratory viruses.

[33]  Mark R. Duffy,et al.  Novel Influenza A (H1N1) outbreak at the U.S. Air Force Academy: epidemiology and viral shedding duration. , 2010, American journal of preventive medicine.